Product Launches
ModuleMD Showcases WISE Touch AI and SkinSight for Allergy Practices at ACAAI 2026
By News Desk ·
Key takeaways
- ModuleMD showcased WISE Touch AI at Booth #1713 during the 2026 ACAAI Annual Scientific Meeting in Phoenix.
- JOSH converts natural conversations into structured clinical notes and supports more than 75 languages.
- SkinSight uses image-based AI to measure wheal and flare reactions and supports documentation for CPT 95004.
ModuleMD showcased a new generation of AI-powered capabilities for its allergy EHR platform at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting in Phoenix, the company said in a PR Newswire release on November 21, 2026. The showcase centered on the continued development of the ModuleMD EHR platform and its latest WISE Touch AI experience.
Inside the WISE Touch AI Platform
At Booth #1713, ModuleMD presented WISE Touch AI as a redesigned clinical experience that brings AI-assisted documentation, clinical decision support and CPT suggestions closer to the point of care. The company said the platform is built around three areas: clinical productivity, administrative automation and access to practice intelligence.
AI-powered clinical documentation with JOSH converts natural conversations into structured clinical notes and supports more than 75 languages. ModuleMD Front Desk extends AI into practice operations through five specialized agents covering patient intake, scheduling, insurance eligibility and estimates, authorizations and referrals, coordinated by a supervisor agent. ModuleMDQ adds conversational practice intelligence, letting practice teams query their data in natural language.
SkinSight introduces image-based AI measurement into skin testing. Using images captured on a device already available to the practice, SkinSight detects and measures wheal and flare reactions, with structured results and timestamped images transferred directly into the patient's chart. The company said the technology supports documentation for CPT 95004.
Following its recent WISE Touch first-look webinar, ModuleMD said it has seen considerable interest and positive feedback from existing clients. "The response reflected strong interest in the direction of the platform, particularly the opportunity to bring clinical documentation, front-office automation and practice intelligence closer together," the company said.
ModuleMD's Allergy Claims Reach 10 Million
According to akta.pro company records, ModuleMD launched SkinSight AI in 2025 as a computer vision solution for allergy skin test measurement and documentation. The same records show the company's data report is based on 10+ million Allergy & Immunology claims from 2021 to 2025, and that it is trusted by practices in 30 states across 5 time zones.
Earlier Showcases and Reports
In November 2026, ModuleMD showcased its connected platform and AI capabilities at CHEST 2026 in Phoenix, targeting independent pulmonary and sleep medicine practices, PR Newswire reported. In July 2026, the company released a thought leadership report, Volume II, offering Allergy & Immunology practices guidance on improving financial performance through operational excellence and KPI optimization rather than patient volume growth, according to PR Newswire.
ModuleMD's Website
ModuleMD directs practices to its company website for more information on its platform.